Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3500
+0.0310 (9.72%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Turnstone Biologics Market Cap
Turnstone Biologics has a market cap or net worth of $8.10 million as of April 25, 2025. Its market cap has decreased by -90.42% in one year.
Market Cap
8.10M
Enterprise Value
-19.64M
1-Year Change
-90.42%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since the IPO on July 21, 2023, Turnstone Biologics's market cap has decreased from $255.86M to $8.10M, a decrease of -96.83%. That is a compound annual growth rate of -85.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 8.10M | -29.53% |
| Dec 31, 2024 | 11.49M | -80.45% |
| Dec 29, 2023 | 58.77M | -77.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |